MannKind Corp
NASDAQ:MNKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MannKind Corp
NASDAQ:MNKD
|
US |
|
KDB Tifa Finance Tbk PT
IDX:TIFA
|
ID |
|
C
|
Chorus Ltd
F:7CH
|
NZ |
|
E
|
Ekachai Medical Care PCL
SET:EKH
|
TH |
|
S
|
Scor SE
DUS:SDRC
|
FR |
|
F
|
Fortive Corp
SWB:F03
|
US |
|
Enagas SA
MAD:ENG
|
ES |
|
Team Internet Group PLC
F:4CN
|
UK |
Intrinsic Value
Is MNKD undervalued or overvalued?
See the intrinsic value estimate for MannKind Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MNKD looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MNKD’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What MannKind Does
MannKind Corp is a biopharmaceutical company that develops and sells inhaled medicines. Its best-known product is Afrezza, a fast-acting mealtime insulin that patients breathe in through a small inhaler instead of injecting. The company also works with other drug makers to adapt medicines for delivery through its inhaled platform.
- Headquarters
- United States of America US
- Employees
- 592
- IPO date
- Jul 28, 2004
Revenue & Expenses Breakdown
MannKind Corp
Earnings Waterfall
MannKind Corp
The intrinsic value for MannKind Corp (MNKD) under the Base Case is hidden USD.
Compared with the current market price of 3.175 USD, the stock appears hidden.